Corrigendum to ‘Health-related quality of life in patients with advanced well-differentiated pancreatic and extrapancreatic neuroendocrine tumors treated with surufatinib versus placebo: Results from two randomized, double-blind, phase III trials (SANET-p and SANET-ep)’ [European Journal of Cancer 169 (2022) 1–9]

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of cancer (1990) 2023-01, Vol.178, p.247-248
Hauptverfasser:	Li, Jiarui, Cheng, Yuejuan, Bai, Chunmei, Xu, Jianming, Shen, Lin, Li, Jie, Zhou, Zhiwei, Li, Zhiping, Chi, Yihebali, Yu, Xianjun, Li, Enxiao, Xu, Nong, Liu, Tianshu, Lou, Wenhui, Bai, Yuxian, Yuan, Xianglin, Wang, Xiuwen, Yuan, Ying, Chen, Jia, Guan, Sha, Fan, Songhua, Su, Weiguo
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!